Patients Want Doctors to Disclose Ties to Industry in MS Trials

This article originally appeared here.
Share this content:
Patients Want Doctors to Disclose Ties to Industry in MS Trials
Patients Want Doctors to Disclose Ties to Industry in MS Trials

(HealthDay News) -- Disclosure of physician-industry relationships is important for potential participants in multiple sclerosis clinical trials and may impact participation in these trials, according to a study published online Feb. 25 in the Multiple Sclerosis Journal.

Andrew J. Solomon, M.D., from the University of Vermont College of Medicine, and colleagues used an anonymous online instrument to examine attitudes of 597 patients with multiple sclerosis concerning disclosure of potential physician-industry conflicts of interest created by clinical trials. The authors further assessed the impact of disclosure of these conflicts of interest on study participation.

The researchers found that detailed disclosure of conflicts of interest was important for potential participants in industry-sponsored trials for multiple sclerosis therapies. The presence of these conflicts might influence patient participation in these trials.

"Findings from this study support a call for uniform guidelines regarding disclosure of physician-industry relationships to prospective research participants for industry-sponsored clinical trials," the authors write.

Several authors disclosed financial ties to the pharmaceutical and biotechnology industries.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Pharmacists Should Counsel Patients Fasting for Ramadan

Pharmacists Should Counsel Patients Fasting for Ramadan

Pharmacists can suggest adjustments for meds taken several times per day, those affected by food intake

AUA: Many Have Unused Opioids After Urologic Procedures

AUA: Many Have Unused Opioids After Urologic Procedures

Patients use just over half of initial prescription; highest percentage of unused meds for cystectomy

Over Half of Young Adult Smoke Volume Exposure From Hookahs

Over Half of Young Adult Smoke Volume Exposure ...

Toxicant exposure to tar, carbon monoxide, nicotine lower, but still substantial, compared to cigarettes

is free, fast, and customized just for you!

Already a member?

Sign In Now »